(Q33560464)

28 July 2017

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography (English)

1 reference

28 July 2017

Abhasnee Sobhonslidsuk

object named as

Abhasnee Sobhonslidsuk

5

0 references

author name string

Kanittha Ratchatasettakul

1

1 reference

28 July 2017

Sasivimol Rattanasiri

2

1 reference

28 July 2017

Kwannapa Promson

3

1 reference

28 July 2017

Pranee Sringam

4

1 reference

28 July 2017

13 April 2017

1 reference

28 July 2017

1 reference

28 July 2017

17

1 reference

28 July 2017

1

1 reference

28 July 2017

50

1 reference

https://scigraph.springernature.com/pub.10.1186/s12876-017-0609-6

28 July 2017

0 references

cites work

Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Fatty liver: imaging patterns and pitfalls

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Nonalcoholic fatty liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5390386

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12876-017-0609-6

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

21 January 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

PubMed

12 December 2020

Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease

1 reference

PubMed

12 December 2020

10.1186/S12876-017-0609-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference